APIM Therapeutics
Birgitte Gangmark Villmo is currently an Investment Manager at Investinor, the largest Norwegian venture fund and investor in APIM Therapeutics. Birgitte has a Master’s degree in Financial Economics from NTNU and a Master of Finance from Massachusetts Institute of Technology (MIT). Prior to her engagement at Investinor, she formerly worked 5 years at Norges Bank Investment Management (NBIM) as a graduate trainee and analyst, mainly in London where she was also seconded to UBS Investment Bank for one year. Before joining Investinor, Birgitte worked for a shorter period at NTNU and for a real estate company in Chile.
This person is not in the org chart
This person is not in any offices
APIM Therapeutics
APIM Therapeutics is developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen).